Sikai Ling, Xue Zhang, Yao Dai, Zhuofan Jiang, Xujiao Zhou, Sicong Lu et al. Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy. // Nature Nanotechnology. – 2025. – DOI: 10.1038/s41565-024-01851-7. – URL: https://doi.org/10.1038/s41565-024-01851-7
Sikai Ling, Xue Zhang, Yao Dai, Zhuofan Jiang, Xujiao Zhou, Sicong Lu, Xiaoqing Qian, Jianping Liu, Niklas Selfjord, Tugce Munise Satir, Anders Lundin, Julia Liz Touza, Mike Firth, Natalie Van Zuydam, Bilada Bilican, Pinar Akcakaya, Jiaxu Hong, & Yujia Cai (2025). Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy. Nature Nanotechnology. https://doi.org/10.1038/s41565-024-01851-7
Sikai Ling, et al. “Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy.” Nature Nanotechnology, 2025. doi:10.1038/s41565-024-01851-7.
@article{Ling2025,
title = {Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy},
author = {Ling, Sikai and Zhang, Xue and Dai, Yao and Jiang, Zhuofan and Zhou, Xujiao and Lu, Sicong and Qian, Xiaoqing and Liu, Jianping and Selfjord, Niklas and Satir, Tugce Munise and Lundin, Anders and Touza, Julia Liz and Firth, Mike and Zuydam, Natalie Van and Bilican, Bilada and Akcakaya, Pinar and Hong, Jiaxu and Cai, Yujia},
journal = {Nature Nanotechnology},
year = {2025},
doi = {10.1038/s41565-024-01851-7},
url = {https://doi.org/10.1038/s41565-024-01851-7}
}